Multicenter study about an effect of Vinorelbine for recurrent brteast cancer

Multicenter study about an effect of Vinorelbine for recurrent brteast cancer - Naberubine study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002491

Enrollment

Registered

2009-12-01

Start date

2009-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

chemotherapy

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: recurrent breast cancer patient PS as 0-1

Exclusion criteria

Exclusion criteria: poor prognoses and poor PS

Design outcomes

Primary

Measure	Time frame
tumor size	—

Secondary

Measure	Time frame
side effect	—

Countries

Japan

Contacts

Public ContactAkira Tangoku

Tokushima University Hospital Department of esophageal, breast and thyroid diseases

surgery2@clin.med.tokushima-u.ac.jp088-633-7143

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026